TCIM
AMPH icon

TIAA CREF Investment Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

TIAA CREF Investment Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.47M Sell
71,797
-246
-0.3% -$5.51K ﹤0.01% 2146
2018
Q4 		$1.43M Sell
72,043
-1,776
-2% -$35K ﹤0.01% 2137
2018
Q3 		$1.42M Sell
73,819
-5,168
-7% -$92.1K ﹤0.01% 2285
2018
Q2 		$1.21M Sell
78,987
-52,955
-40% -$925K ﹤0.01% 2415
2018
Q1 		$2.47M Buy
131,942
+41,848
+46% +$787K ﹤0.01% 2000
2017
Q4 		$1.73M Sell
90,094
-5,860
-6% -$109K ﹤0.01% 2211
2017
Q3 		$1.72M Sell
95,954
-2,196
-2% -$36.1K ﹤0.01% 2249
2017
Q2 		$1.75M Sell
98,150
-16,518
-14% -$262K ﹤0.01% 2253
2017
Q1 		$1.66M Sell
114,668
-15,626
-12% -$246K ﹤0.01% 2244
2016
Q4 		$2.4M Sell
130,294
-7,503
-5% -$146K ﹤0.01% 2083
2016
Q3 		$2.61M Buy
137,797
+6,372
+5% +$116K ﹤0.01% 2031
2016
Q2 		$2.12M Buy
131,425
+27,684
+27% +$391K ﹤0.01% 2080
2016
Q1 		$1.25M Sell
103,741
-33,900
-25% -$400K ﹤0.01% 2352
2015
Q4 		$1.96M Buy
137,641
+32,422
+31% +$428K ﹤0.01% 2169
2015
Q3 		$1.23M Buy
105,219
+30,563
+41% +$458K ﹤0.01% 2440
2015
Q2 		$1.31M Buy
74,656
+53,094
+246% +$827K ﹤0.01% 2554
2015
Q1 		$323K Hold
21,562
– – ﹤0.01% 3001
2014
Q4 		$250K Buy
21,562
+2,467
+13% +$26.9K ﹤0.01% 3074
2014
Q3 		$222K Buy
+19,095
New +$199K ﹤0.01% 3082

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

TIAA CREF Investment Management's AMPH Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Amphastar Pharmaceuticals (AMPH) stake by 0.34% in Q1 2019, selling an estimated $5.51K and leaving 71,797 shares worth $1.47M. The position accounts for ﹤0.01% of the portfolio, ranked #2146.

TIAA CREF Investment Management first reported a position in AMPH in Q3 2014 and has held it in 19 quarters since. The position peaked at $2.61M in Q3 2016. 135 funds tracked by Wall St. Rank hold AMPH as of Q1 2019.

  • TIAA CREF Investment Management held 71,797 shares of Amphastar Pharmaceuticals worth $1.47M as of Q1 2019.
  • TIAA CREF Investment Management sold 246 Amphastar Pharmaceuticals shares in Q1 2019, an estimated $5.51K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2146 holding.
  • TIAA CREF Investment Management first reported a position in Amphastar Pharmaceuticals in Q3 2014 and has held it in 19 quarters since.
  • TIAA CREF Investment Management's Amphastar Pharmaceuticals position peaked at $2.61M in Q3 2016.
  • 135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.